基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗
Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The spatial immune landscape predicts outcome and reveals the central role of tumor-associated macrophages in inflammatory breast cancer biology.
The spatial immune landscape predicts outcome and reveals the central role of tumor-associated macrophages in inflammatory breast cancer biology.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
这些结果凸显了 IBC 微环境的免疫抑制性质以及 TAMs 在促进侵袭性 IBC 表型中的作用。决定预后的关键因素是空间背景和免疫细胞之间的平衡,而非总体丰度。我们的发现强调了在预后评估中考虑免疫细胞定位的重要性,并支持进一步研究针对 TAM 的疗法在 IBC 中的应用。
炎性乳腺癌(IBC)是一种罕见但侵袭性强的乳腺癌亚型,以快速进展和预后不良为特征。尽管其具有独特的临床表现和分子特征,但IBC的免疫景观及其在驱动侵袭性表型中的潜在作用仍知之甚少。本研究旨在表征IBC的空间免疫景观,将其与亚型匹配的非炎性乳腺癌(nIBC)进行比较,并评估免疫细胞组成和定位的预后意义。
我们分析了161例IBC和115例亚型匹配的nIBC患者的治疗前肿瘤样本,采用免疫组织化学(IHC)检测CD8、FOXP3、CD79α、CD163和PD-L1。数字图像分析量化了肿瘤区域(TA)和浸润边缘(IM)中的免疫细胞密度和相对标记物面积。使用多变量逻辑回归和Cox比例风险模型评估了与临床病理特征、新辅助化疗(NACT)病理反应和生存的关联。使用Affymetrix基因表达数据和共识TME解卷积进行转录组验证。
IBC 显示 CD163+ 肿瘤相关巨噬细胞(TAM)浸润高于 nIBC。基因表达数据证实了 IHC 结果,通路分析将高 TAM 密度与炎症和增殖通路联系起来。免疫细胞的空间分布具有预后相关性,高 CD8+ T 细胞浸润(OR:0.41,95% CI:0.22-0.76,P = 0.004)和低 CD79α+ B 细胞浸润(OR:3.19,95% CI:1.68-6.03,P < 0.001)与 IBC 总生存期改善相关。此外,TA 内 CD8+ T 细胞与 FOXP3+ 调节性 T 细胞的比值是一个显著的预后指标(OR:0.34,95% CI:0.14-0.83,P = 0.018),而单独 CD8+ 或 FOXP3+ T 细胞的绝对密度与结局无关。
Inflammatory breast cancer (IBC) is a rare but aggressive subtype of breast cancer characterized by rapid progression and poor prognosis. Despite its distinct clinical presentation and molecular features, the immune landscape of IBC and its potential role in driving the aggressive phenotype remain poorly understood. This study aimed to characterize the spatial immune landscape of IBC, compare it with that of subtype-matched non-inflammatory breast cancer (nIBC), and evaluate the prognostic implications of immune cell composition and localization.
We analyzed pre-treatment tumor samples from 161 IBC and 115 subtype-matched nIBC patients using immunohistochemistry (IHC) for CD8, FOXP3, CD79α, CD163, and PD-L1. Digital image analysis quantified the immune cell density and relative marker area in the tumor area (TA) and invasive margin (IM). Associations with clinicopathological features, pathological response to neoadjuvant chemotherapy (NACT), and survival were assessed using multivariate logistic regression and Cox proportional hazards models. Transcriptomic validation was performed using Affymetrix gene expression data and consensus TME deconvolution.
IBC showed higher infiltration of CD163 + tumor-associated macrophages (TAMs) compared to nIBC. Gene expression data confirmed IHC findings, and pathway analysis linked high TAM density with inflammatory and proliferative pathways. The spatial distribution of immune cells was prognostically relevant, with high CD8 + T-cell infiltration (OR: 0.41, 95% CI: 0.22-0.76, P = 0.004) and low CD79α + B-cell infiltration (OR: 3.19, 95% CI: 1.68-6.03, P < 0.001) correlating with improved overall survival in IBC. Furthermore, the ratio of CD8+ T-cells to FOXP3+ regulatory T-cells within the TA was a significant prognostic indicator (OR: 0.34, 95% CI: 0.14-0.83, P = 0.018), whereas the absolute densities of either CD8+ or FOXP3 + T-cells alone were not associated with outcome.
These results highlight the immunosuppressive nature of the IBC microenvironment and the role of TAMs in promoting an aggressive IBC phenotype. Spatial context and the balance between the immune cells, rather than the overall abundance, was critical in determining outcome. Our findings underscore the importance of considering immune cell localization in prognostic assessment and support further investigation of TAM-targeted therapies in IBC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。